September’s unemployment rate fell to 6.43% from August’s 8.3%. However, behind this statistic lies the fact that the share of the working-age population that is actually working is still less than in pre-pandemic times

India’s tryst with the cattle-killer disease so far has been similar to earlier experiences of outbreaks in the Middle East and Africa. This should worry authorities at home

Four labor codes are set to be operationalized by the government soon. These laws will benefit big corporates at the expense of workers and make organizing more difficult

The government is ignoring people’s distress and the worsening crisis – and it has no solutions

Over one million Accredited Social Health Activist (ASHA) workers have been awarded the WHO’s Global Health Leaders Award, recognizing their role in ensuring access to care in a health system that is still widely inaccessible, and increasingly privatized

Immunologist Dr. Satyajit Rath and Newsclick’s Prabir Purkayastha talk about how a clear definition of a COVID-19-related death is essential for good public health policy

Immunologist Dr. Satyajit Rath and NewsClick’s Prabir Purkayastha take a look at the debate around when the COVID-19 pandemic might turn endemic

Immunologist Dr. Satyajit Rath and NewsClick’s Prabir Purkayastha review the COVID-19 situation in India, and also talk about the possibilities of the Corbevax vaccine

Immunologist Dr. Satyajit Rath discusses the rising number of Omicron cases in major countries, as well as the high positivity rate in metropolitan cities in India

Immunologist Dr. Satyajit Rath talks about the Omicron variant, which seems to have displaced Delta in India and could infect more people than its predecessor

Today we look at new threats facing Wet’suwet’en water protectors in Canada, the killing of a Palestinian man by Israeli forces in the West Bank, and more

Immunologist Dr. Satyajit Rath and NewsClick’s Prabir Purkayastha discuss the emerging Omicron situation and new vaccines that have received the emergency use approval in India, including the oral-drug Molnupiravir